Key Takeaways
- PVC price crash triggers destocking, but margins hold: A 13.5% single-quarter drop in PVC prices froze the dealer channel, yet Astral kept consolidated EBITDA margin within its 16% to 18% guided range without sacrificing market share.
- Growth engines are being built, not bought: The quarter was defined by heavy upfront investment across paints, U.S. new products, bath ware, and the Bharat adhesive initiative, all of which management argues will convert to profit as revenue scales over the next year.
- Regulatory tailwinds are now live: The government imposed an antidumping duty on PVC imports and BIS quality enforcement is advancing, both of which should lift domestic PVC prices by INR6 to INR8 and flush out non-compliant competitors.
- International businesses are a drag with a deadline: The U.K. posted negative EBITDA and the U.S. launch costs compressed margins; management expects both to normalize and deliver growth within two quarters.
- What to watch next quarter: Whether the INR6-8 PVC price rise materializes and flows through to volume, the pace of inventory destocking reversal by November-end, and any concrete cost control savings beyond the INR25 crores already achieved.
PVC Price Volatility & Channel Destocking
- The 13.5% price shock: PVC prices fell sharply during the quarter, triggering a freeze as dealers and distributors slashed normal inventory levels to avoid holding depreciating stock. The extended monsoon and a festive-season demand lull compounded the slowdown.
- Destocking depth: Management described "reasonably high destocking at the dealer and distributor level" because nobody wanted inventory with prices still falling. The channel should refill in the coming 3-4 weeks, with clarity expected by November-end.
- Volume growth still intact: Despite the destocking, Astral expects to end the fiscal year with 10% to 15% volume growth, with the wider range reflecting uncertainty over how quickly the channel restocks.
- Price recovery mechanics: The government's antidumping duty circular arrived just before the call; Astral has already taken an INR3 price rise and expects a total INR6 to INR8 increase over time, with roughly 40-50% of that already effected through the duty amendment.
- BIS as a second catalyst: A BIS hearing in December is expected to further tighten supply by eliminating non-certified imports, with implementation likely within one or two quarters. Management flagged that if traders stop importing, a PVC shortage could emerge in Q4.
- Inventory gain optionality: The company built inventory planning for 15%+ growth; with antidumping duty now in place, it expects a gain on that older, lower-cost stock as prices rise, and a "drastic" inventory drawdown in Q3.
Engineer: "So managing the EBITDA and still selling more product was the first criteria which as Astral we did, and we never lost our market share."
Margin Resilience & Cost Structure
- Margin held within guided range: Consolidated EBITDA margin stayed at 16%, inside the 15-16% guided band, despite the PVC price collapse, extended monsoon, and new-business investment drag.
- Other expenses fell sharply: Other expenses dropped from INR219 crores to INR194 crores (15.9% to 14.2% of revenue) sequentially, with management saying there is a "high probability" of further decline.
- Employee cost spike is temporary: Higher employee costs reflect six structural drivers: the Bharat adhesive rural push, paint expansion into three new states, U.S. plant staffing for 12-14 new chemistries, Hyderabad plant startup, bath ware regional expansion, and flat revenue optically inflating the ratio. Management expects normalization by fiscal year-end and has begun manpower rationalization that takes 2-3 quarters.
- Cost control is real but undisclosed: Management confirmed cost control is reflected in the numbers but declined to enumerate specific measures or quantify absolute savings, saying "we cannot give you what numbers... Let us also drive it." Further benefits are expected in coming quarters as new-business revenue converts.
- Inventory loss acknowledged: A slight inventory loss of INR10-15 crores occurred during the quarter, though management noted the amount was not substantial enough to have been precisely worked out.
- No price wars: Management explicitly rejected dropping prices to chase volume, arguing that once a price is lowered, recovery takes 6 months to a year, and that competitors taking shortcuts on quality are not a model Astral will follow.
Savlani: "As communicated in the past several times, our company is always believing in profitable growth. And we have again demonstrated that in Q2, you can see our margins are maintained within our guided range of 16% to 18% and overall 15% to 16% on a consolidated basis."
New Business Investment Cycle
- The "stone by stone" build: Management framed elevated costs across paints, U.S. adhesives, bath ware, and the Bharat adhesive initiative as deliberate investment, not cash burn. The thesis: initial costs are always high, fruit comes later, and full benefit arrives the year after next.
- Paint business reset: Paint revenue guidance has been lowered continuously; FY25 may not achieve FY23 paint revenue. Management attributes this to delayed launch and dealer onboarding, not competitive pressure. No capex has been spent on paint since acquisition, margins are never negative, and the business is now live in four states (Gujarat, Maharashtra, Karnataka, Rajasthan). The ask: "give us 1 year to 2 years and you will see a steady business."
- U.S. launch costs: Twelve to fourteen new chemistries (waterproofing, silicones, oxeyes, hybrids) are now running at the U.S. plant, but the associated manpower build-out (plant, QC, purchase, sales) compressed margins for one or two quarters. Products previously exported from the U.K. will now be made locally.
- Bath ware scaling: Two new regions (East and Seven Sisters) were opened, delivering positive acceptance and numbers. Full-year revenue is expected between INR100-125 crores.
- Adhesives history as precedent: Management pointed to the adhesive business, which faced similar challenges for three years post-acquisition and is now number two in India after nine years, as the template for current new-vertical patience.
Engineer: "we are not doing anything burning any cash. We are building business. We are building a very strong Astral with all these four verticals, which will be more stronger in coming time."
International Business: U.K. & U.S.
- U.K. EBITDA turned negative: The U.K. business posted minus 2% EBITDA due to large-player destocking that changed the sales mix toward lower-margin products. The U.K. standalone is not loss-making; U.S. losses flow through the U.K. entity. Marketing executive performance was also flagged as a challenge, with necessary changes underway.
- U.K. recovery timeline: Management expects a return to normal EBITDA in two quarters, with performance resuming from Q4 and double-digit growth with normal margins thereafter. Advanced-technology adhesives developed in the U.K. will launch in the next two quarters, with similar products also launching in India in Q3 or Q4.
- U.S. margin compression: Launching 12-14 new products required adding manpower across plant, QC, purchase, and sales functions, which hit margins for one or two quarters. Management expects the U.S. to deliver "a good number and a good margin" within two quarters as those products begin selling.
- Adhesives margin split: India adhesives margins have been consistently maintained at 15%+; any consolidated margin contraction visible is from the U.K. operation. Normalized margins: India 14-16%, U.K. 8-10%. Management did not provide a normalized margin for the U.S. business.
Engineer: "U.K. business is 9 years only, given tons of money. One or two quarters does not shake up the business."
Capacity Expansion & New Product Pipeline
- Hyderabad plant: Pipe production has started alongside the initial water tank line, with 21,000 metric tons of initial capacity in place and further machines to be added in Q4.
- Ghiloth fitting expansion: Twenty-two new machines are almost ready and will start production from November, adding 4,000 metric tons of fitting capacity.
- OPVC entry: The first OPVC machine is installed with trial productions completed and tested to ISI specifications in the laboratory; commercial production awaits ISI approval. Two additional OPVC machines are expected to be commissioned in Q3, placed at different locations to serve different states and minimize transport cost. First full-year revenue target after all three machines are operational: more than INR100 crores.
- Valve division: A new range of 50 SKUs covering ball, thick ball, and non-return valves from 0.5 inch to 4 inch for PVC and CPVC will begin commercial production in Q4.
- PTMT range: A new product range with 150 SKUs is ready to launch in December, with revenue starting from Q4.
- Infra pipe capacity: Double-wall corrugated pipe capacity is being expanded by 5,000 metric tons by Q4, with corrugators ordered and being delivered to enable production from almost every plant pan-India. The company has also started exporting some infra products, which is helping realization.
- Kanpur greenfield: Construction is on plan; initial trials of water tanks and some products are expected at the end of Q4, with production starting in the first quarter of next fiscal.
- Silencio technology: Astral developed its own silent-pipe technology with partner companies, owning and governing it without royalties or technology cost, using more economical machines.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| PVC volume growth | 10% to 15% volume growth for FY25 | FY25 full year |
| Consolidated EBITDA margin | 15% to 16% (normal business margin 16-18% excluding inventory gain) | Ongoing |
| U.K. business recovery | Return to normal EBITDA, double-digit growth | Within 2 quarters (Q4 onwards) |
| U.S. business performance | Delivering good growth and good margin | Within 2 quarters |
| Employee cost normalization | Manpower cost ratio to normalize as revenue scales | By fiscal year-end |
| Bath ware full-year revenue | INR100 crores to INR125 crores | FY25 |
| OPVC first full-year revenue | More than INR100 crores | First full fiscal after all 3 machines operational |
| Capex FY25 | More or less in line with earlier guidance (~INR350 cr); balance over INR100 cr | FY25 |
| Inventory normalization | Drastic reduction in Q3 driven by antidumping duty | Q3 FY25 |
| Paint business | Cross FY23 revenue number | 1 to 2 years |
| Adhesives U.K. turnaround | Double-digit growth (~10%) | From next year |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Consolidated revenue | ₹1,370 cr, +0.5% YoY |
| Consolidated EBITDA | ₹219 cr, -6% YoY |
| Consolidated EBITDA margin | 16.0%, vs 17.0% YoY |
| Plumbing (pipes) revenue | ₹966 cr, -1.4% YoY |
| Plumbing (pipes) EBITDA margin | 18.3%, vs 18.0% YoY; guided range 16%–18% |
| Plumbing volume growth guidance (FY25) | 10%–15%, 1H at 6.5% |
| Adhesives India revenue | ₹263 cr, +9% YoY |
| Adhesives India EBITDA margin | 15.5%, vs 15.4% YoY; guided range 14%–16% |
| Adhesives U.K. revenue | ₹92 cr, flat YoY (₹93 cr) |
| Adhesives U.K. EBITDA margin | -2%, vs 9.7% YoY; normalized guided 8%–10% |
| Paint revenue | ₹49 cr, +5% YoY |
| Paint EBITDA margin | 5.35%, vs 22.4% YoY (₹2.6 cr vs ₹10.3 cr) |
| Bath ware revenue | ₹28.9 cr, +63% YoY; monthly run rate ₹10 cr |
| Bath ware full-year revenue guidance | ₹100 cr–₹125 cr |
| Inventory loss (PVC price decline) | ₹10 cr–₹15 cr estimated |
| Other expenses (consolidated) | ₹194 cr, down from ₹219 cr QoQ; 14.2% of revenue vs 15.9% |
| Capex (1H FY25) | ₹282 cr |
| OPVC first full-year revenue target | >₹100 cr |